ATP-sensitive potassium channels: Diverse functions in the central nervous system

Neuroscientist

Volumn 2, Issue 3, 1996, Pages 145-152

  Freedman, Jonathan E ^a   Lin, Yong Jian ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Dopamine; Excitotoxicity; Patch clamp; Potassium channels; Satiety; Sulfonylureas

Indexed keywords

EID: 0000793097     PISSN: 10738584     EISSN: None     Source Type: Journal    
DOI: 10.1177/107385849600200309     Document Type: Review

References (84)

1. + channels in cardiac muscle. Nature 1983;305:147-148.
2. Ashcroft SJH, Ashcroft FM. The sulfonylurea receptor. Biochim Biophys Acta 1992;1175:45-59.
3. Edwards G, Weston AH. The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 1993;33:597-637.
4. ATP channels. Clin Exp Pharmacol Physiol 1994;21:583-597.
5. Takeshita K, Yamagishi I, Sugimoto T, Otomo S, Moriwaki K. The hair growing effect of minoxidil. Ann N Y Acad Sci 1991; 642:470-472.
6. Malaisse WJ. Stimulation of insulin release by non-sulfonylurea hypoglycemic agents: the meglitinide family. Horm Metab Res 1995;27:263-266.
7. ATP channel. Nature 1994; 370:456-459.
8. Inagaki N, Tsuura Y, Namba N, et al. Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle and heart. J Biol Chem 1995;270:5691-5694.
9. Bredt DS, Wang T-L, Cohen NA, Guggino WB, Snyder SH. Cloning and expression of two brain-specific inwardly rectifying potassium channels. Proc Natl Acad Sci U S A 1995;92:6753-6757.
10. + channels. Trends Pharmacol Sci 1993;14:320-323.
11. +-channel proteins. Nature 1995;374:135-141.
12. Bond CT, Ammala C, Ashfield R, et al. Cloning and functional expression of the cDNA encoding an inwardly-rectifying potassium channel expressed in pancreatic β-cells and in the brain. FEBS Lett 1995;367:61-66.
13. 2+ of the inward rectifier, IRK1. J Physiol (Lond) 1994;478:1-6.
14. + channel. Nature 1994;371:243-246.
15. + channels localized to a single negatively charged residue. Nature 1994;371:246-249.
16. + channels. Science 1994;264:844-847.
17. Pessia M, Bond CT, Kavanaugh MP, Adelman JP. Contributions of the C-terminal domain to gating properties of inward rectifier potassium channels. Neuron 1995;14:1039-1045.
18. + channel. Neuron 1995;14:1047-1054.
19. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA. HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 1995;269:92-95.
20. Aguilar-Bryan L, Nichols CG, Wechsler SW, et al. Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995;268:423-426.
21. Thomas PM, Cote GJ, Wohllk N, et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995;268:426-429.
22. Al-Awqati Q. Regulation of ion channels by ABC transporters that secrete ATP. Science 1995;269:805-806.
23. Virsolvy-Vergine A, Leray H, Kuroki S, Lupo B, Dufour M, Bataille D. Endosulfine, an endogenous peptidic ligand for the sulfonylurea receptor: purification and partial characterization from ovine brain. Proc Natl Acad Sci U S A 1992;89:6629-6633.
24. Ho K, Nichols CG, Lederer WJ, et al. Cloning and expression of an inwardly rectifying ATP-regulated potassium channel. Nature 1993;362:31-38.
25. ATP channels in rat ventricular myocytes. Pflugers Arch 1993;422:617-619.
26. + channels. Am J Physiol Heart Circ Physiol 1994;266:H613-H622.
27. + channels by antagonizing ATP-dependent gating. Neuron 1994;12:885-893.
28. + channel in guinea-pig ventricular cell membrane. J Physiol (Lond) 1994;478:101-107.
29. + channel, GIRK1. Biochem Biophys Res Commun 1995;212:1022-1028.
30. + channels in arterial smooth muscle. Science 1989;245:177-180.
31. + current in cat atrial myocytes. Am J Physiol Heart Circ Physiol 1995;268:H1322-H1334.
32. + channel in rabbit esophageal smooth muscle. Am J Physiol Cell Physiol 1995;268:C877-C885.
33. + channels to A, receptors by G-proteins in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 1990;259: H820-H826.
34. + channels in cerebral ischemic preconditioning. Proc Natl Acad Sci U S A 1995;92:4666-4678.
35. + channels. Nature 1990;344:770-773.
36. Lin Y-J, Greif GJ, Freedman JE. Multiple sulfonylurea-sensitive potassium channels: a novel subtype modulated by dopamine. Mol Pharmacol 1993;44:907-910.
37. + channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res 1992;70:612-616.
38. + channels in insulin-secreting cells via a pertussis-sensitive G-protein. EMBO J 1989;8:412-420.
39. Ben-Ari Y. Galanin and glibenclamide modulate the anoxic release of glutamate in rat CA3 hippocampal neurons. Eur J Neurosci 1990;2:62-68.
40. ATP channel in insulin-secreting cells. J Membr Biol 1994;142:395-408.
41. + channel openers and blocked by antidiabetic sulfonylureas. Proc Natl Acad Sci U S A 1991;88:5438-5442.
42. + channel of vascular smooth muscle cells. FEBS Lett 1994;345:47-49.
43. 2D-adrenergic receptor contraction of arteriolar smooth muscle and reversal of contraction by hypoxia. Circ Res 1995;76:53-63.
44. Randall MD, McCulloch AI. The involvement of ATP-sensitive potassium channels in β-adrenoceptor-mediated vasorelaxation in the rat isolated mesenteric arterial bed. Br J Pharmacol 1995;115: 607-612.
45. Raggozino ME, Gold PE. Task-dependent effects of intra-amygdala morphine injections: attenuation by intra-amygdala glucose injections. J Neurosci 1994;14:7478-7485.
46. Ocana M, Delpozo E, Barrios M, Robles LI, Baeyens JM. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol 1990;186:377-378.
47. + channels. Brain Res 1994;650:146-148.
48. Jackson WF, Konig A, Dambacher T, Busse R. Prostacyclin-induced vasodilation in rabbit heart is mediated by ATP-sensitive potassium channels. Am J Physiol Heart Circ Physiol 1993;264: H238-H243.
49. Zhang H, Cook D. Antagonism of eicosanoid-induced contraction of rat aorta by sulphonylureas. Pharmacology 1994;49:173-183.
50. + channels in insulinoma cells: activation by somatostatin and protein kinase C and the role of cAMP. Proc Natl Acad Sci U S A 1989;86:2971-2975.
51. +-channel activities of cultured smooth muscle cells from porcine coronary artery. Am J Physiol Heart Circ Physiol 1992;263:H491-H496.
52. + current in the human neuroblastoma cell line SH-SY5Y. Neurosci Lett 1992;135:37-40.
53. Karadi Z, Faludi B, Lenard L, et al. Glucose-sensitive neurons of the globus pallidus: II. Complex functional attributes. Brain Res Bull 1995;37:157-162.
54. Ashcroft SJH, Ashcroft FM. Properties and functions of ATP-sensitive K-channels. Cell Signal 1990;2:197-214.
55. + channel of rat neocortical neurons is bi-gated by intracellular ATP and voltage: a novel channel gating mechanism? Neurosci Lett 1995;193:93-96.
56. + channels suggest multiple targets for inhibitory drug molecules. J Membr Biol 1994;142:309-322.
57. + channels in clonal pancreatic α cells: evidence for two high affinity sulfonylurea receptors. J Biol Chem 1993;268:15221-15228.
58. 3H]glibenclamide in the rat brain. Brain Res 1991;542:151-154.
59. Faivre JF, Findlay I. Effects of tolbutamide, glibenclamide and diazoxide upon action potentials recorded from rat ventricular muscle. Biochim Biophys Acta 1989;984:1-5.
60. + channels and block neurosecretion. Proc Natl Acad Sci U S A 1990;87: 3489-3492.
61. Stanford IM, Lacey MG. Regulation of a potassium conductance in rat midbrain dopamine neurons by intracellular adenosine triphosphate (ATP) and the sulfonylureas tolbutamide and glibenclamide. J Neurosci 1995;15:4651-4657.
62. Sellers AJ, Boden PR, Ashford MLJ. Lack of effect of potassium channel openers on ATP-modulated potassium channels recorded from rat ventromedial hypothalamic neurones. Br J Pharmacol 1992;107:1068-1074.
63. Boden P, Ashford MLJ, Treheme JM. Actions of sulfonylureas on neurones of rat ventromedial hypothalamus in vitro. Br J Pharmacol 1989;98(Suppl):830P.
64. B receptors in isolated substantia nigra neurones. Pflugers Arch 1990;416:473-475.
65. +) channel in dopaminergic neurones of the rat substantia nigra. Neurosci Lett 1992;141:213-217.
66. Greif GJ, Lin Y-J, Liu J-C, Freedman JE. Dopamine-modulated potassium channels on rat striatal neurons: specific activation and cellular expression. J Neurosci 1995;15:4533-4544.
67. + channels on rat striatal neurons. Neuroreport 1995;6:1277-1280.
68. Greif GJ, Lin Y-J, Freedman JE. Role of cyclic AMP in dopamine modulation of potassium channels on rat striatal neurons: regulation of a subconductance state. Synapse. 1995;21:275-277.
69. + channel in spiny neurons of rat caudate nucleus. Pflugers Arch 1994;427:187-189.
70. + channel blocker: comparison with rat insulinoma cells. Mol Pharmacol 1994;46:139-145.
71. + channel blockers in rats. J Cardiovasc Pharmacol 1995;25:404-409.
72. Ohrnberger CE, Kahn SA, Meisheri KD. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists. J Pharmacol Exp Ther 1993;267:25-30.
73. ATP channels on nerve terminals of the rat motor cortex. Br J Pharmacol 1995;115: 385-388.
74. Ginsberg MD. Neuroprotection in brain ischemia: an update (part II). NEUROSCIENTIST 1995;1:164-175.
75. + channel in substantia nigra neurons. J Neurosci 1994;14:5590-5602.
76. + channels in cultured rat hippocampal neurons: activation by cromakalim and energy-depleting conditions. Mol Pharmacol 1991;40:308-315.
77. + channels reduce anoxic depolarization in CA3 hippocampal neurons. Neurosci 1990;37:55-60.
78. Globus MY-T, Busto R, Dietrich WD, Martinez E, Valdes I, Ginsberg MD. Effect of ischemia on the in vivo release of striatal dopamine, glutamate and γ-aminobutyric acid studied by intracerebral microdialysis. J Neurochem 1988;51:1455-1464.
79. Amano T, Ujihara H, Matsubayashi H, et al. Dopamine-induced protection of striatal neurons against kainate receptor-mediated glutamate cytotoxicity in vitro. Brain Res 1994;655:61-69.
80. Goldman-Rakic P. Cerebral cortical mechanisms in schizophrenia. Neuropsychopharmacology 1994;10(3 Suppl, Pt 1):22S-27S.
81. Benes FM. Is there a neuroanatomic basis for schizophrenia? An old question revisited. NEUROSCIENTIST 1995;1:104-115.
82. Arnold SE, Lee VM-Y, Our RE, Trojanowski JQ. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci U S A 1991;88:10850-10854.
83. Jakob H, Beckmann H. Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenic and clinical aspects. J Neural Transm 1994;98:83-106.
84. Matesic DF, Lin RCS. Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J Neurochem 1994;63:1012-1020.